SCHEMBL2998158

SCHEMBL2998158

CCOC(=O)N1CCc2cc(C(=O)NC3CCCC3)sc2CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.55
RAB9A P51151 3/20 0.55
PRNP P04156 1/20 0.54
ALDH1A1 P00352 5/20 0.51
HTT P42858 1/20 0.51
HDAC6 Q9UBN7 2/20 0.47
KDM4E B2RXH2 4/20 0.47
HSD17B10 Q99714 3/20 0.47
HPGD P15428 2/20 0.47
THRB P10828 1/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAPK1 P28482 2/20 0.45
GAA P10253 2/20 0.45
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11176901 0.80 KDM4E (0.48) NPC1RAB9AALDH1A1HTTHDAC6
SCHEMBL11180673 0.80 ALDH1A1 (0.51) ALDH1A1HDAC6KDM4EHPGDL3MBTL1
SCHEMBL1181655 0.77 HDAC6 (0.47) ALDH1A1HTTHDAC6KDM4EHPGD
SCHEMBL3044274 0.77 ALDH1A1 (0.42) NPC1RAB9AALDH1A1HTTHDAC6
SCHEMBL1181893 0.76 HDAC6 (0.45) ALDH1A1HTTHDAC6KDM4EHPGD
SCHEMBL13560073 0.76 ALDH1A1 (0.43) ALDH1A1HTTKDM4EL3MBTL1CYP3A4
SCHEMBL1181044 0.74 HDAC6 (0.40) ALDH1A1HTTHDAC6KDM4EHPGD
SCHEMBL13266222 0.74 HDAC6 (0.43) ALDH1A1HDAC6KDM4EL3MBTL1CYP3A4
SCHEMBL984992 0.74 POLB (0.47) ALDH1A1HTTKDM4EHSD17B10L3MBTL1
SCHEMBL2993002 0.74 GRM5 (0.41) NPC1RAB9AALDH1A1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778243-B1 SUBSTITUTED AZEPINE DERIVATIVES AS SEROTONIN RECEPTOR MODULATORS ATHERSYS INC (US) 2012-10-31 EP disclosed
US-20100190772-A1 Substituted Azepine Derivatives As Serotonin Receptor Modulators BENNANI YOUSSEF L 2010-07-29 US disclosed
US-7718647-B2 Substituted azepine derivatives as serotonin receptor modulators ATHERSYS, INC. (US) 2010-05-18 US disclosed
EP-1778243-A2 SUBSTITUTED AZEPINE DERIVATIVES AS SEROTONIN RECEPTOR MODULATORS Athersys, Inc. (US) 2007-05-02 EP disclosed
WO-2006004931-A2 SUBSTITUTED AZEPINE DERIVATIVES AS SEROTONIN RECEPTOR MODULATORS ATHERSYS, INC. (US) 2006-01-12 WO disclosed
US-20060003990-A1 Substituted azepine derivatives as serotonin receptor modulators ATHERSYS, INC. 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060003990-A1 Substituted azepine derivatives as serotonin receptor modulators HTR5A, HTR4, HTR7 NPC1 1560/4885RAB9A 2779/4885PRNP 2456/4885
US-20100190772-A1 Substituted Azepine Derivatives As Serotonin Receptor Modulators HTR5A, HTR4, HTR2C NPC1 1552/4885RAB9A 2563/4885PRNP 2039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.